ADARB2 and acute myeloid leukemia: We next sought to determine whether changes in LINC01257 or ADARB2-AS1 lncRNA expression could alter the proliferation and survival of Kasumi-1 AML cells; a cell line derived from a 7-year-old boy in relapse and used here as a model of t(8;21)-translocated pediatric AML.